Filing Details
- Accession Number:
- 0001562180-23-008571
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-28 16:38:37
- Reporting Period:
- 2023-12-26
- Accepted Time:
- 2023-12-28 16:38:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | Pharmaceutical Preparations (2834) | 821725586 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1853529 | J Alan Russell | C/O Edgewise Therapeutics, Inc. 1715 38Th Street Boulder CO 80301 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-12-26 | 172,585 | $9.33 | 3,606 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price.
Billionaire Hedge Funds
